Allarity Therapeutics, Inc. (ALLR) Financials
ALLR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 34.9 million | 28.0 million |
| Dec. 31, 2025 | 18.3 million | 8.4 million |
| Sept. 30, 2025 | 20.8 million | 8.8 million |
| June 30, 2025 | 21.2 million | 9.0 million |
ALLR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -4.6 million | 160000 |
| Dec. 31, 2025 | -3.3 million | 47000 |
| Sept. 30, 2025 | -3.4 million | 132000 |
| June 30, 2025 | -5.5 million | 164000 |
ALLR Net Income
No data available :(
ALLR Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 19.8 million | - | - |
| Dec. 31, 2025 | 14.7 million | - | - |
| Sept. 30, 2025 | 16.9 million | - | - |
| June 30, 2025 | 17.8 million | - | - |
ALLR Shares Outstanding
ALLR Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 64000 | 1.3 million | 1.4 million | - |
| Dec. 31, 2025 | - | 1.7 million | 1.6 million | - |
| Sept. 30, 2025 | - | 1.2 million | 1.3 million | - |
| June 30, 2025 | - | 2.3 million | 1.8 million | - |
ALLR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 25000 | -26000 |
| Dec. 31, 2025 | 320000 | - |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | 12000 |
ALLR
Price: $1.43
52 week price:
Earnings Per Share: -0.70 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 959260
Market Capitalization: 25.6 million